Ceftazidime - Revision history

Danbot: Remove disease-specific dosing covered by dynamic SMW tables

2026-03-20T02:57:48Z

Remove disease-specific dosing covered by dynamic SMW tables

← Older revision		Revision as of 02:57, 20 March 2026
Line 10:		Line 10:
	*1 g IV/IM q8-12h		*1 g IV/IM q8-12h
	**Max: 6 g/day		**Max: 6 g/day
	~~===[[Pneumonia]], Hospital-acquired or ventilator-associated===~~
	*2 g IV q8h x7 days


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Ceftazidime]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Ceftazidime]] [[Has Population::Adult]]

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:38:32Z

Restore original dosing content alongside dynamic SMW tables

← Older revision		Revision as of 02:38, 20 March 2026
Line 7:		Line 7:

	==Adult Dosing==		==Adult Dosing==
			===Infections, Bacterial===
			*1 g IV/IM q8-12h
			**Max: 6 g/day
			===[[Pneumonia]], Hospital-acquired or ventilator-associated===
			*2 g IV q8h x7 days


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Ceftazidime]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Ceftazidime]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==
			===Infections, Bacterial===
			*Neonates 0-7 days old
			**100 mg/kg/day IM/IV divided q12h
			*Neonates >7 days old, <1200g
			**100mg/kg/day IM/IV divided q12h
			*Neonates >7 days old, >1200g
			**150mg/kg/day IM/IV divided q8h
			*1mo - 12yo
			**90-150 mg/kg/day IM/IV divided q8h
			***Max: 6 g/day
			***Reserve high dose for immunocompromised, cystic fibrosis, or meningitis


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Ceftazidime]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Ceftazidime]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

Danbot: Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

2026-03-20T01:52:23Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

← Older revision		Revision as of 01:52, 20 March 2026
Line 7:		Line 7:

	==Adult Dosing==		==Adult Dosing==
	===~~Infections, Bacterial~~===		===Indications by Disease===
	*1 g IV/IM q8-12h		{{#ask: [[Has DrugName::Ceftazidime]] [[Has Population::Adult]]
	**Max: 6 g/day		\|?Treats disease=Disease
	===~~[[Pneumonia]], Hospital~~-~~acquired or ventilator-associated=~~==		\|?Has Dose=Dose
	*2 g IV q8h x7 days		\|?Has Context=Context
			\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Pediatric Dosing==		==Pediatric Dosing==
	===~~Infections, Bacterial~~===		===Indications by Disease===
	*Neonates 0-7 days old		{{#ask: [[Has DrugName::Ceftazidime]] [[Has Population::Pediatric]]
	**100 mg/kg/day IM/IV divided q12h		\|?Treats disease=Disease
	*Neonates >7 days old, <1200g		\|?Has Dose=Dose
	**100mg/kg/day IM/IV divided q12h		\|?Has Context=Context
	*Neonates >7 days old, >1200g		\|format=table
	**150mg/kg/day IM/IV divided q8h		\|limit=50
	*1mo - ~~12yo~~		\|mainlabel=-
	**90-150 mg/kg/day IM/IV divided q8h		\|headers=show
	***Max: 6 g/day		\|sort=Treats disease
	***Reserve high dose for immunocompromised, cystic fibrosis, or meningitis		}}

	==Special Populations==		==Special Populations==

Ostermayer at 16:20, 18 July 2025

2025-07-18T16:20:05Z

← Older revision		Revision as of 16:20, 18 July 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: ~~Third~~ generation [[Is DrugClass::cephalosporin]]		*Type: [[Is Generation::3rd generation]] [[Is DrugClass::cephalosporin]]
	*Dosage Forms: injectable solution, powder for injection		*Dosage Forms: injectable solution, powder for injection
	*Dosage Strengths: injectable solution: 20mg/mL, 40mg/mL; powder for injection: 500mg, 1g, 2g, 6g		*Dosage Strengths: injectable solution: 20mg/mL, 40mg/mL; powder for injection: 500mg, 1g, 2g, 6g

Ostermayer at 14:48, 18 July 2025

2025-07-18T14:48:54Z

← Older revision		Revision as of 14:48, 18 July 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: Third generation [[cephalosporin]]		*Type: Third generation [[Is DrugClass::cephalosporin]]
	*Dosage Forms: injectable solution, powder for injection		*Dosage Forms: injectable solution, powder for injection
	*Dosage Strengths: injectable solution: 20mg/mL, 40mg/mL; powder for injection: 500mg, 1g, 2g, 6g		*Dosage Strengths: injectable solution: 20mg/mL, 40mg/mL; powder for injection: 500mg, 1g, 2g, 6g

ClaireLewis at 22:02, 19 September 2019

2019-09-19T22:02:30Z

← Older revision		Revision as of 22:02, 19 September 2019
Line 211:		Line 211:
	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]]

Humanguy: /* General */ edited dosage forms, strengths, trade names

2017-10-13T18:16:54Z

General: edited dosage forms, strengths, trade names

← Older revision		Revision as of 18:16, 13 October 2017
Line 1:		Line 1:
	==General==		==General==
	*Type: Third generation [[cephalosporin]]		*Type: Third generation [[cephalosporin]]
	*Dosage Forms: IV/IM		*Dosage Forms: injectable solution, powder for injection
	*Common Trade Names: Fortaz, Tazicef		*Dosage Strengths: injectable solution: 20mg/mL, 40mg/mL; powder for injection: 500mg, 1g, 2g, 6g
			*Routes of Administration: IV, IM
			*Common Trade Names: Fortaz, Tazicef, Tazidime

	==Adult Dosing==		==Adult Dosing==

Mholtz at 23:11, 30 August 2017

2017-08-30T23:11:20Z

← Older revision		Revision as of 23:11, 30 August 2017
Line 2:		Line 2:
	*Type: Third generation [[cephalosporin]]		*Type: Third generation [[cephalosporin]]
	*Dosage Forms: IV/IM		*Dosage Forms: IV/IM
	*Common Trade Names: ~~Fotaz~~, Tazicef		*Common Trade Names: Fortaz, Tazicef

	==Adult Dosing==		==Adult Dosing==

Mholtz at 23:10, 30 August 2017

2017-08-30T23:10:49Z

← Older revision		Revision as of 23:10, 30 August 2017
Line 206:		Line 206:
	*[[Antibiotics (Main)]]		*[[Antibiotics (Main)]]

	==~~Source~~==		==References==
			<references/>

	~~<references/>~~
	[[Category:Pharmacology]]		[[Category:Pharmacology]]

Jonwarren: Updated dosing, pharmacology, contraindications, and complications

2017-08-14T16:10:11Z

Updated dosing, pharmacology, contraindications, and complications

← Older revision		Revision as of 16:10, 14 August 2017
Line 1:		Line 1:
	==General==		==General==
	*Type: Third generation [[cephalosporin]]		*Type: Third generation [[cephalosporin]]
	*Dosage Forms:		*Dosage Forms: IV/IM
	*Common Trade Names:		*Common Trade Names: Fotaz, Tazicef

	==Adult Dosing==		==Adult Dosing==
			===Infections, Bacterial===
			*1 g IV/IM q8-12h
			**Max: 6 g/day
			===[[Pneumonia]], Hospital-acquired or ventilator-associated===
			*2 g IV q8h x7 days

	==Pediatric Dosing==		==Pediatric Dosing==
			===Infections, Bacterial===
			*Neonates 0-7 days old
			**100 mg/kg/day IM/IV divided q12h
			*Neonates >7 days old, <1200g
			**100mg/kg/day IM/IV divided q12h
			*Neonates >7 days old, >1200g
			**150mg/kg/day IM/IV divided q8h
			*1mo - 12yo
			**90-150 mg/kg/day IM/IV divided q8h
			***Max: 6 g/day
			***Reserve high dose for immunocompromised, cystic fibrosis, or meningitis

	==Special Populations==		==Special Populations==
	*Pregnancy:		*Pregnancy: C; May use during pregnancy
	*Lactation:		*Lactation: No known risk
	*Renal Dosing		*Renal Dosing
	**Adult		**Adult
			***CrCl 31-50: Give q12h
			***CrCl 16-30: Give q24h
			***CrCl 6-15: 1 g x1, then 500mg q24h
			***CrCl <5: 1 g x1, then 500mg q48h
			***HD: 1 g x1, then give 1 g after dialysis, no supplement
			***PD: 1 g x1, then 500mg q24h, no supplement
	**Pediatric		**Pediatric
			***CrCl 30-50: Give q12h
			***CrCl 10-29: Give q24h
			***CrCl <10: Give q48h
			***HD/PD: No supplement

	*Hepatic Dosing		*Hepatic Dosing
	**Adult		**Adult: No adjustment
	**Pediatric		**Pediatric: No adjustment

	==Contraindications==		==Contraindications==
	*Allergy to class/drug		*Allergy to class/drug
			*Caution:
			**Hypersensitivity to [penicillin]
			**Renal impairment
			**Concurrent nephrotoxic agent
			**Seizure disorder
			**Recent abx-associated colitis

	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
			*[[Seizure]]
			*[[Agranulocytosis]]
			*[[Thrombocytopenia]]
			*[[Anemia]], hemolytic
			*[[Anaphylaxis]]
			*C. difficile-associated diarrhea

	===Common===		===Common===
			*[[Diarrhea]]
			*[[Nausea]]/[[Vomiting]]
			*Abdominal pain
			*[[Rash]]
			*Pruritus
			*Urticaria
			*[[Headache]]
			*Dizziness
			*ALT, AST elevation
			*BUN, Cr elevation

	==Pharmacology==		==Pharmacology==
	*Half-life:		*Half-life: 1.9h
	*Metabolism:		*Metabolism: Minimal
	*Excretion:		*Excretion: Urine primarily
	*Mechanism of Action:		*Mechanism of Action: Bactericidal; inhibits cell wall mucopeptide synthesis

	==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==		==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==